Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Merge service

May 26, 2023

No comments

About the author.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent blog post.

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market

Posted: 6 months ago
Podcast: Healthcare Insights by KYBORA

Posted: 6 months ago
Managing Director – Biopharma Investment Banking (Broker-Dealer Head)

Posted: 7 months ago
KYBORA at BioArbor Life Science Forum

Posted: 7 months ago
Podcast: Healthcare Insights by KYBORA

Posted: 7 months ago

Tags.

#biopharma Licensing AI Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

Contact Us

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market

Posted: 6 months ago
Podcast: Healthcare Insights by KYBORA

Posted: 6 months ago

Terms of service | Privacy policy

Merge service

About the author.

Drcom Content Editor

No Comments. Leave a comment

Leave a Reply

Recent blog post.

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market

Podcast: Healthcare Insights by KYBORA

Managing Director – Biopharma Investment Banking (Broker-Dealer Head)

KYBORA at BioArbor Life Science Forum

Podcast: Healthcare Insights by KYBORA

TYPE & ENTER: